This webinar provides an in-depth focus on the recognition and prevention of technical issues that occur in ICC, and guidance on ways to ensure ICC quality in diagnostic Cellular Pathology. After the session, attendees will be able to: • Select high quality antibodies appropriate for the demonstration of common tissue biomarkers • Evaluate the staining of new antibodies and methodologies and identify quality staining results • Resolve issues associated with antibody titres, retrieval protocols and non-specific staining
A Técnica de Patologia Celular NEQAS do Reino Unido é operada pela LabXCell Ltd, uma empresa sem fins lucrativos registrada na Inglaterra e no País de Gales (Empresa nº 5311646).
